FedEx Projects Compound Annual Growth Rate For Adj. EPS Of 14-19% Through FY25

FedEx Corp. (FDX) said the company is targeting to deliver 18-22% annualized TSR through fiscal 2025. The company expects compound annual growth rate for adjusted EPS of 14-19% through fiscal 2025. It also targets 4-6% compound annual revenue growth through fiscal 2025. FedEx estimates fiscal 2025 adjusted consolidated operating income improvement of $3.0-$4.5 billion compared to fiscal 2022 adjusted consolidated operating income.

The company's other financial goals for fiscal 2025 include: 10% adjusted consolidated operating margin; and adjusted dividend payout ratio of at least 25%.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
IBSA Pharma Inc. is recalling 27 lots of TIROSINT-SOL (levothyroxine sodium) Oral Solution to the consumer level due to subpotency, the U.S. Food and Drug Administration said. TIROSINT-SOL is indicated for Hypothyroidism and Pituitary Thyrotropin (Thyroid-Stimulating Hormone, TSH) Suppression. Meanwhile, the recall does not apply to TIROSINT (levothyroxine sodium) capsules. The U.S. Food and Drug Administration approved GlaxoSmithKline LLC's Jesduvroq tablets (daprodustat) for anemia caused by chronic kidney disease or CKD for adults who have been receiving dialysis for at least four months. It is the first oral treatment for anemia, i.e., decreased number of red blood cells, in the given indication that has received FDA approval. German banking major Deutsche Bank AG reported Thursday a significantly higher profit in its fourth quarter and fiscal 2022, mainly reflecting a tax benefit in the U.S, despite weakness in Investment Bank and asset management revenues. The company said it recorded its highest annual profit, both before and after tax, since 2007. However, Deutsche Bank shares were losing around 4 percent...
Follow RTT